IL17A and rheumatoid arthritis: Driving forces in the pathogenesis of RA and experimental arthritides are cytokines such as tumor necrosis factor alpha (TNF-alpha), interleukin-1 alpha/beta (IL-1 alpha/beta), interleukin-6 (IL-6) and interleukin-17 (IL-17) (2).